Report Detail
Global (United States, European Union and China) Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Research Report 2019-2025
- RnM3660089 |
- 09 August, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
DTaP (also DTPa and TDaP) is a combined vaccine against diphtheria, tetanus, and pertussis, in which the pertussis component is acellular. This is in contrast to whole-cell, inactivated DTP (aka DTwP). The acellular vaccine uses selected antigens of the pertussis pathogen to induce immunity. Because it uses fewer antigens than the whole cell vaccines, it is considered safer, but it is also more expensive. Recent research suggests that the DTP vaccine is more effective than DTaP in conferring immunity; this is because DTaP's narrower antigen base is less effective against current pathogen strains.
In 2019, the market size of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine.
This report studies the global market size of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Sanofi Pasteur
GlaxoSmithKline
Protein Sciences Corporation
Novartis AG
Seqirus
Merck Sharp & Dohme Corp
Astellas Pharma US, Inc
Pfizer Inc
Johnson & Johnson
Lanzhou Institute of Biological Products Co., Ltd
AstraZeneca
Emergent BioSolutions Inc
Market Segment by Product Type
Immune DTaP Vaccine
Therapy DTaP Vaccine
Market Segment by Application
Adult
Pediatric
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Immune DTaP Vaccine
- 1.3.3 Therapy DTaP Vaccine
- 1.4 Market Segment by Application
- 1.4.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Application (2019-2025)
- 1.4.2 Adult
- 1.4.3 Pediatric
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size
- 2.1.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue 2014-2025
- 2.1.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales 2014-2025
- 2.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Growth Rate by Regions
- 2.2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Regions 2014-2019
- 2.2.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Manufacturers
- 3.1.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Manufacturers 2014-2019
- 3.1.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Manufacturers (2014-2019)
- 3.2.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Concentration Ratio (CR5 and HHI)
- 3.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price by Manufacturers
- 3.4 Key Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market
- 3.6 Key Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Immune DTaP Vaccine Sales and Revenue (2014-2019)
- 4.1.2 Therapy DTaP Vaccine Sales and Revenue (2014-2019)
- 4.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type
- 4.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Type
- 4.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application
6 United States
- 6.1 United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Company
- 6.2 United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Type
- 6.3 United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Application
7 European Union
- 7.1 European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Company
- 7.2 European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Type
- 7.3 European Union Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Application
8 China
- 8.1 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Company
- 8.2 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Type
- 8.3 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Company
- 9.2 Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Type
- 9.3 Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Application
- 9.4 Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Breakdown Data by Countries
- 9.4.1 Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Countries
- 9.4.2 Rest of World Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Sanofi Pasteur
- 10.1.1 Sanofi Pasteur Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
- 10.1.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction
- 10.1.5 Sanofi Pasteur Recent Development
- 10.2 GlaxoSmithKline
- 10.2.1 GlaxoSmithKline Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
- 10.2.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction
- 10.2.5 GlaxoSmithKline Recent Development
- 10.3 Protein Sciences Corporation
- 10.3.1 Protein Sciences Corporation Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
- 10.3.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction
- 10.3.5 Protein Sciences Corporation Recent Development
- 10.4 Novartis AG
- 10.4.1 Novartis AG Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
- 10.4.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction
- 10.4.5 Novartis AG Recent Development
- 10.5 Seqirus
- 10.5.1 Seqirus Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
- 10.5.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction
- 10.5.5 Seqirus Recent Development
- 10.6 Merck Sharp & Dohme Corp
- 10.6.1 Merck Sharp & Dohme Corp Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
- 10.6.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction
- 10.6.5 Merck Sharp & Dohme Corp Recent Development
- 10.7 Astellas Pharma US, Inc
- 10.7.1 Astellas Pharma US, Inc Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
- 10.7.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction
- 10.7.5 Astellas Pharma US, Inc Recent Development
- 10.8 Pfizer Inc
- 10.8.1 Pfizer Inc Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
- 10.8.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction
- 10.8.5 Pfizer Inc Recent Development
- 10.9 Johnson & Johnson
- 10.9.1 Johnson & Johnson Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
- 10.9.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction
- 10.9.5 Johnson & Johnson Recent Development
- 10.10 Lanzhou Institute of Biological Products Co., Ltd
- 10.10.1 Lanzhou Institute of Biological Products Co., Ltd Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
- 10.10.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction
- 10.10.5 Lanzhou Institute of Biological Products Co., Ltd Recent Development
- 10.11 AstraZeneca
- 10.12 Emergent BioSolutions Inc
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Channels
- 11.2.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Distributors
- 11.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Customers
12 Market Forecast
- 12.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Revenue Forecast 2019-2025
- 12.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast by Type
- 12.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast by Application
- 12.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Forecast by Regions
- 12.4.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Forecast by Regions 2019-2025
- 12.4.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine . Industry analysis & Market Report on Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine is a syndicated market report, published as Global (United States, European Union and China) Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
